189 related articles for article (PubMed ID: 20351279)
1. A theoretical framework for gene induction and experimental comparisons.
Ong KM; Blackford JA; Kagan BL; Simons SS; Chow CC
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7107-12. PubMed ID: 20351279
[TBL] [Abstract][Full Text] [Related]
2. Inferring mechanisms from dose-response curves.
Chow CC; Ong KM; Dougherty EJ; Simons SS
Methods Enzymol; 2011; 487():465-83. PubMed ID: 21187235
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
4. Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation.
Kim Y; Sun Y; Chow C; Pommier YG; Simons SS
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):3-17. PubMed ID: 16723222
[TBL] [Abstract][Full Text] [Related]
5. Deducing the temporal order of cofactor function in ligand-regulated gene transcription: theory and experimental verification.
Dougherty EJ; Guo C; Simons SS; Chow CC
PLoS One; 2012; 7(1):e30225. PubMed ID: 22272313
[TBL] [Abstract][Full Text] [Related]
6. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
Tao YG; Xu Y; Xu HE; Simons SS
Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
[TBL] [Abstract][Full Text] [Related]
7. Theory of partial agonist activity of steroid hormones.
Chow CC; Ong KM; Kagan B; Simons SS
AIMS Mol Sci; 2015; 2(2):101-123. PubMed ID: 25984562
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
Szapary D; Huang Y; Simons SS
Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
[TBL] [Abstract][Full Text] [Related]
9. Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction.
Pradhan MA; Blackford JA; Devaiah BN; Thompson PS; Chow CC; Singer DS; Simons SS
J Biol Chem; 2016 Jan; 291(1):342-54. PubMed ID: 26504077
[TBL] [Abstract][Full Text] [Related]
10. Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression.
Li L; Andersen ME; Heber S; Zhang Q
J Mol Endocrinol; 2007 May; 38(5):569-85. PubMed ID: 17496158
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of steroid binding to receptors and steroid induction of biological activity in a glucocorticoid-responsive cell.
Mercier L; Thompson EB; Simons SS
Endocrinology; 1983 Feb; 112(2):601-9. PubMed ID: 6129134
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptors.
Rousseau GG; Baxter JD
Monogr Endocrinol; 1979; 12():49-77. PubMed ID: 386089
[TBL] [Abstract][Full Text] [Related]
13. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.
Simons SS
Bioessays; 2008 Aug; 30(8):744-56. PubMed ID: 18623071
[TBL] [Abstract][Full Text] [Related]
14. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
15. Steroid binding to hepatoma tissue culture cell glucocorticoid receptors involves at least two sulfhydryl groups.
Miller NR; Simons SS
J Biol Chem; 1988 Oct; 263(29):15217-25. PubMed ID: 3170579
[TBL] [Abstract][Full Text] [Related]
16. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
17. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
18. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
Sarlis NJ; Bayly SF; Szapary D; Simons SS
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone antagonism and a cyclic model of receptor kinetics.
Munck A; Holbrook NJ
J Steroid Biochem; 1987 Feb; 26(2):173-9. PubMed ID: 3560934
[TBL] [Abstract][Full Text] [Related]
20. The road less traveled: new views of steroid receptor action from the path of dose-response curves.
Simons SS; Chow CC
Mol Cell Endocrinol; 2012 Jan; 348(2):373-82. PubMed ID: 21664235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
